Cortex Pharmaceuticals Inc.: The Irvine developer of...
- Share via
Cortex Pharmaceuticals Inc.: The Irvine developer of drugs for neurological and psychiatric disorders posted a net loss of $1.3 million, or 14 cents a share, for the first fiscal quarter ended Sept. 30, compared with a net loss of $1.2 million, or 16 cents a share, for the corresponding prior year period. No revenue was reported.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
